Education no heart failure predictorUPI.com14 (UPI) — People with higher levels of education usually have better health outcomes but US researchers say education is not a predictor for managing heart failure. Karen S. Yehle, an assistant professor of …
12 brain operations, kidney and liver failure and blind in both eyes, but boy … – Daily Mail
Daily Mail12 brain operations, kidney and liver failure and blind in both eyes, but boy …Daily MailHis distraught parents watched him endure 12 brain operations, kidney and liver failure, paralysis and going blind in both eyes. Now, at five years old…
The Knuths are Adopting – WGBA-TV
The Knuths are AdoptingWGBA-TVBy Eric Peterson You'll remember five-year-old Charlie Knuth is recovering nicely after a stem-cell transplant nearly a year ago. Now, the Knuth family is making room for six-year-old Seth, and they're asking the c…
Woman gets kidney after posting Craigslist ad – msnbc.com
New York Daily NewsWoman gets kidney after posting Craigslist admsnbc.com"Living donors are very unique individuals," said Dr. Linda Chen of the Jackson Memorial Hospital on the University of Miami Medical Center Campus, where Hodge and Grant…
5 Stocks Winning 52-Week Highs as DJIA and S&P Decline 1% Today – Wall St. Cheat Sheet
5 Stocks Winning 52-Week Highs as DJIA and S&P Decline 1% TodayWall St. Cheat SheetThe Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection …
Less Is More for Rituximab in Low-Burden Follicular Lymphoma – Medscape
Less Is More for Rituximab in Low-Burden Follicular LymphomaMedscapeDecember 14, 2011 — For patients with low-tumor-burden follicular lymphoma, new data suggest that treatment with rituximab (Rituxan, Genentech) is better than a "watch-and-wait&…
Premiere Cooperative Group in Adult Lymphoma Research (GELA) Chooses … – CNBC – San Francisco Luxury News
Premiere Cooperative Group in Adult Lymphoma Research (GELA) Chooses … – CNBCSan Francisco Luxury NewsThe combination of REVLIMID (lenalidomide) and rituximab, also referred to as the R-squared (or R(2)) regimen pioneered by Nathan Fowler, MD and col…
PBSCs from unrelated donors linked to higher rates of chronic GVHD – HemOncToday
PBSCs from unrelated donors linked to higher rates of chronic GVHDHemOncTodayAlthough PBSCs from related donors have been shown to have clinical benefit, Anasetti told HemOnc Today that these results show that PSBCs from unrelated donors put patients a…
ASH: Continuous Tx Yields Better Results in Multiple Myeloma – MedPage Today
ASH: Continuous Tx Yields Better Results in Multiple MyelomaMedPage TodayA recent study indicated that maintenance therapy with lenalidomide (Revlimid) should be the standard of care for older patients with newly diagnosed multiple myeloma who are not …
Novel monoclonal antibody targets CD20 in relapsed NHL – HemOncToday
Novel monoclonal antibody targets CD20 in relapsed NHLHemOncTodaySAN DIEGO — The novel anti-CD20 monoclonal antibody obinutuzumab was linked to better response rates than rituximab in a cohort of patients with relapsed non-Hodgkin's lymphoma, acc…